Carisma Therapeutics, Inc.CARMNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
25.95%
↑ 103% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-844.68%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 25.95% | +109.0% |
| 2024 | -289.45% | +49.7% |
| 2023 | -575.74% | -0.8% |
| 2022 | -571.36% | -1679.2% |
| 2021 | -32.11% | +87.1% |
| 2020 | -248.58% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | +100.0% |
| 2017 | -6763.29% | -87463.3% |
| 2016 | 7.74% | - |